Cargando…
“Repurposing” Disulfiram in the Treatment of Lyme Disease and Babesiosis: Retrospective Review of First 3 Years’ Experience in One Medical Practice
A total of 71 patients with Lyme disease were identified for analysis in whom treatment with disulfiram was initiated between 15 March 2017 and 15 March 2020. Four patients were lost to follow-up, leaving 67 evaluable patients. Our retrospective review found patients to fall into a “high-dose” group...
Autores principales: | Gao, Jiachen, Gong, Zhaodi, Montesano, Dawn, Glazer, Erica, Liegner, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761882/ https://www.ncbi.nlm.nih.gov/pubmed/33291557 http://dx.doi.org/10.3390/antibiotics9120868 |
Ejemplares similares
-
Disulfiram (Tetraethylthiuram Disulfide) in the Treatment of Lyme Disease and Babesiosis: Report of Experience in Three Cases
por: Liegner, Kenneth B.
Publicado: (2019) -
Lyme Disease, Anaplasmosis, and Babesiosis, Atlantic Canada
por: Allehebi, Ziyad O., et al.
Publicado: (2022) -
Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
por: Kannappan, Vinodh, et al.
Publicado: (2021) -
Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram
por: Zhang, Gong, et al.
Publicado: (2022) -
Repurposing Disulfiram as an Antifungal Agent: Development of a New Disulfiram Vaginal Mucoadhesive Gel
por: Lajarin-Reinares, Maria, et al.
Publicado: (2023)